Company Name | City | State | Country/Region | Website | Service Type |
---|---|---|---|---|---|
Creyon Bio, Inc. | Carlsbad | California | United States | ceyonbio.com | Core Company |
Crinetics Pharmaceuticals Inc. | San Diego | California | United States | crinetics.com | Core Company |
CRISPR QC | San Diego | California | United States | crisprqc.com | Core Company |
Crossbow Therapeutics, Inc. | Cambridge | Massachusetts | United States | Core Company | |
Crossignal Therapeutics | La Jolla | California | United States | crossignaltherapeutics.com | Core Company |
Crown Bioscience Inc. | Santa Clara | California | United States | crownbio.com | General Company |
Crucell | Leiden | Netherlands | crucell.com | Core Company | |
CSL Behring | King of Prussia | Pennsylvania | United States | cslbehring.com | Core Company |
CSL Limited | Parkville | Victoria | Australia | csl.com.au | Core Subsidiary |
CSL Vifor | Glattbrugg | Switzerland | https://www.viforpharma.com/us# | Core Subsidiary | |
Curevo, Inc. | Bothell | Washington | United States | curevovaccine.com | Core Company |
Curis, Inc | Lexington | Massachusetts | United States | curis.com | Core Company |
Curza, Inc. | Salt Lake City | Utah | United States | curza.com | Core Company |
Cyan Therapeutics, Inc. | Palo Alto | California | United States | https://bridgebio.com/ | General Company |
Cybin Corp. | Toronto | Ontario | Canada | Core Company | |
Cybrexa Therapeutics | New Haven | Connecticut | United States | cybrexa.com | Core Company |
Cyclacel Pharmaceuticals, Inc | Berkeley Heights | New Jersey | United States | cyclacel.com | Core Company |
Cygnus Technologies, Inc | Leland | North Carolina | United States | cygnustechnologies.com | Core Company |
CymaBay Therapeutics | Fremont | California | United States | cymabay.com | Core Company |
Cypress Biopharma | Cary | North Carolina | United States | cypressbiopharma.com | Core Company |
Biotechnology Innovation Organization
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved